Pharmaceutical Treatment of Fatigue After Aneurysmal Subarachnoid Hemorrhage

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT03209830

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03209830
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Norway (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03209830. Randomized; double masking; primary purpose treatment. Start 2017-09-05 (actual); primary completion 2019-09-13 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pharmaceutical Treatment of Fatigue After Aneurysmal Subarachnoid Hemorrhage
Condition
Aneurysmal Subarachnoid Hemorrhage
Intervention (Drug)
OSU 6162
Intervention (Drug)
Placebo Oral Tablet
Lead sponsor
Oslo University Hospital (class: other)
Collaborator
Göteborg University (class: other)
Collaborator
Sahlgrenska University Hospital (class: other)

Record details

Record id
cardio:ct-nct03209830
Content hash
1ebf411e81afc26f86676e35f89e84adadaa5b15f9faab4e9715dca4bb687d51